ITRM20000041A0 - Derivati glicosamminoglicani parzialmente desolfatati non anticoagulanti ad attivita' antiangiogenica. - Google Patents

Derivati glicosamminoglicani parzialmente desolfatati non anticoagulanti ad attivita' antiangiogenica.

Info

Publication number
ITRM20000041A0
ITRM20000041A0 IT2000RM000041A ITRM20000041A ITRM20000041A0 IT RM20000041 A0 ITRM20000041 A0 IT RM20000041A0 IT 2000RM000041 A IT2000RM000041 A IT 2000RM000041A IT RM20000041 A ITRM20000041 A IT RM20000041A IT RM20000041 A0 ITRM20000041 A0 IT RM20000041A0
Authority
IT
Italy
Prior art keywords
glycosamminoglyc
anticoagulant
derivatives
antiangiogenic activity
partially desulfated
Prior art date
Application number
IT2000RM000041A
Other languages
English (en)
Inventor
Claudio Pisano
Benito Casu
Giancarlo Torri
Anna Maria Naggi
Giuseppe Giannini
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of ITRM20000041A0 publication Critical patent/ITRM20000041A0/it
Priority to IT2000RM000041A priority Critical patent/IT1316986B1/it
Priority to MXPA02007195A priority patent/MXPA02007195A/es
Priority to SI200130686T priority patent/SI1268558T1/sl
Priority to BR0107696-5A priority patent/BR0107696A/pt
Priority to CZ20022308A priority patent/CZ303030B6/cs
Priority to EP01906098A priority patent/EP1268558B1/en
Priority to HK03104131.9A priority patent/HK1051867B/xx
Priority to SK1067-2002A priority patent/SK287566B6/sk
Priority to KR1020027009395A priority patent/KR100812406B1/ko
Priority to PT01906098T priority patent/PT1268558E/pt
Priority to ES01906098T priority patent/ES2277911T3/es
Priority to JP2001561068A priority patent/JP5371167B2/ja
Priority to US10/182,185 priority patent/US20030013682A1/en
Priority to DK01906098T priority patent/DK1268558T3/da
Priority to CNB018040942A priority patent/CN100540570C/zh
Priority to HU0204196A priority patent/HU229509B1/hu
Priority to CA2397964A priority patent/CA2397964C/en
Priority to AU34064/01A priority patent/AU782632B2/en
Priority to PL357209A priority patent/PL209479B1/pl
Priority to PCT/IT2001/000034 priority patent/WO2001055221A1/en
Priority to AT01906098T priority patent/ATE348115T1/de
Priority to DE60125154T priority patent/DE60125154T2/de
Publication of ITRM20000041A1 publication Critical patent/ITRM20000041A1/it
Application granted granted Critical
Publication of IT1316986B1 publication Critical patent/IT1316986B1/it
Priority to US10/967,255 priority patent/US20050107331A1/en
Priority to US11/028,512 priority patent/US7790700B2/en
Priority to US11/314,736 priority patent/US7781416B2/en
Priority to CY20071100140T priority patent/CY1108001T1/el
Priority to US11/882,978 priority patent/US8067555B2/en
Priority to US11/980,741 priority patent/US20080139503A1/en
Priority to US12/851,166 priority patent/US8222231B2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Diabetes (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oncology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
IT2000RM000041A 2000-01-25 2000-01-25 Derivati glicosamminoglicani parzialmente desolfatati nonanticoagulanti ad attivita' antiangiogenica. IT1316986B1 (it)

Priority Applications (29)

Application Number Priority Date Filing Date Title
IT2000RM000041A IT1316986B1 (it) 2000-01-25 2000-01-25 Derivati glicosamminoglicani parzialmente desolfatati nonanticoagulanti ad attivita' antiangiogenica.
CNB018040942A CN100540570C (zh) 2000-01-25 2001-01-24 具有抗血管生成活性且没有抗凝作用的部分脱硫酸化糖胺聚糖的衍生物
HU0204196A HU229509B1 (en) 2000-01-25 2001-01-24 Derivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect, process for their preparation and pharmaceutical compositions containing them
BR0107696-5A BR0107696A (pt) 2000-01-25 2001-01-24 Derivados de glicosaminoglicans parcialmente dessulfatados dotados com atividade antiangiogênica e destituìdos de efeito anticoagulante
CZ20022308A CZ303030B6 (cs) 2000-01-25 2001-01-24 Deriváty cástecne desulfatovaných glykosaminoglykanu s antiangiogenním úcinkem a postrádajících antikoagulacní úcinky
EP01906098A EP1268558B1 (en) 2000-01-25 2001-01-24 Derivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect
HK03104131.9A HK1051867B (en) 2000-01-25 2001-01-24 Derivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect
SK1067-2002A SK287566B6 (sk) 2000-01-25 2001-01-24 Derivát čiastočne desulfátovaných glykózaminoglykánov, spôsob jeho prípravy a použitie
KR1020027009395A KR100812406B1 (ko) 2000-01-25 2001-01-24 혈관형성 억제 활성을 갖고 항응고 효과는 없는부분적으로 탈황산화된 글리코스아미노글리칸의 유도체
PT01906098T PT1268558E (pt) 2000-01-25 2001-01-24 Derivados de glicosaminoglicanos parcialmente dessulfatados dotados com actividade angiogénica e isentos de efeito anticoagulante
ES01906098T ES2277911T3 (es) 2000-01-25 2001-01-24 Derivados de glicosaminoglicanos dotados con actividad antiangiogenica y desprovistos de efecto anticoagulante.
JP2001561068A JP5371167B2 (ja) 2000-01-25 2001-01-24 抗脈管形成活性を有し、かつ、抗凝固作用がない、部分脱硫酸グリコサミノグリカンの誘導体
US10/182,185 US20030013682A1 (en) 2000-01-25 2001-01-24 Derivatives of partially desulphated glycosaminologycans endowed with antiangiogenic activity and devoid of anticogulating effect
DK01906098T DK1268558T3 (da) 2000-01-25 2001-01-24 Derivater af delvist desulfaterede glycosaminoglycaner forsynet med antiangionisk aktivitet og uden antikoagulerende virkning
MXPA02007195A MXPA02007195A (es) 2000-01-25 2001-01-24 Derivados de glucosaminoglucanos parcialmente desulfatado y dotados con actividad antiangiogenica y desprovistos de efectos anticoagulantes.
CA2397964A CA2397964C (en) 2000-01-25 2001-01-24 Derivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect
PCT/IT2001/000034 WO2001055221A1 (en) 2000-01-25 2001-01-24 Derivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect
SI200130686T SI1268558T1 (sl) 2000-01-25 2001-01-24 Delno desulfatizirani derivati glikozaminglikata, ki imajo antiangiogeno delovanje in nimajo antikoagulacijskega delovanja
PL357209A PL209479B1 (pl) 2000-01-25 2001-01-24 2-O-odsiarczanowane pochodne heparyny, sposób ich wytwarzania, kompozycje farmaceutyczne zawierające je oraz zastosowanie
AU34064/01A AU782632B2 (en) 2000-01-25 2001-01-24 Derivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect
AT01906098T ATE348115T1 (de) 2000-01-25 2001-01-24 Teildesulfatierte glykosaminoglykanderivate mit antiangiogenischer aktivität und ohne antikoagulierender wirkung
DE60125154T DE60125154T2 (de) 2000-01-25 2001-01-24 Teildesulfatierte glykosaminoglykanderivate mit antiangiogenischer aktivität und ohne antikoagulierender wirkung
US10/967,255 US20050107331A1 (en) 2000-01-25 2004-10-19 Derivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect
US11/028,512 US7790700B2 (en) 2000-01-25 2005-01-04 Derivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect
US11/314,736 US7781416B2 (en) 2000-01-25 2005-12-22 Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect
CY20071100140T CY1108001T1 (el) 2000-01-25 2007-02-01 Παραγωγα μερικα αποθειωμενων γλυκοζαμινογλυκανων προικισμενα με αντι-αγγειογονο δραστηριοτητα και χωρις αντιπηκτικη επιδραση
US11/882,978 US8067555B2 (en) 2000-01-25 2007-08-08 Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect
US11/980,741 US20080139503A1 (en) 2000-01-25 2007-10-31 Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect
US12/851,166 US8222231B2 (en) 2000-01-25 2010-08-05 Derivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2000RM000041A IT1316986B1 (it) 2000-01-25 2000-01-25 Derivati glicosamminoglicani parzialmente desolfatati nonanticoagulanti ad attivita' antiangiogenica.

Publications (3)

Publication Number Publication Date
ITRM20000041A0 true ITRM20000041A0 (it) 2000-01-25
ITRM20000041A1 ITRM20000041A1 (it) 2001-07-25
IT1316986B1 IT1316986B1 (it) 2003-05-26

Family

ID=11454382

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2000RM000041A IT1316986B1 (it) 2000-01-25 2000-01-25 Derivati glicosamminoglicani parzialmente desolfatati nonanticoagulanti ad attivita' antiangiogenica.

Country Status (21)

Country Link
US (4) US20030013682A1 (it)
EP (1) EP1268558B1 (it)
JP (1) JP5371167B2 (it)
KR (1) KR100812406B1 (it)
CN (1) CN100540570C (it)
AT (1) ATE348115T1 (it)
AU (1) AU782632B2 (it)
BR (1) BR0107696A (it)
CA (1) CA2397964C (it)
CY (1) CY1108001T1 (it)
CZ (1) CZ303030B6 (it)
DE (1) DE60125154T2 (it)
DK (1) DK1268558T3 (it)
ES (1) ES2277911T3 (it)
HU (1) HU229509B1 (it)
IT (1) IT1316986B1 (it)
MX (1) MXPA02007195A (it)
PL (1) PL209479B1 (it)
PT (1) PT1268558E (it)
SK (1) SK287566B6 (it)
WO (1) WO2001055221A1 (it)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7781416B2 (en) 2000-01-25 2010-08-24 Sigma-Tau Research Switzerland S.A. Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect
IT1316986B1 (it) 2000-01-25 2003-05-26 Sigma Tau Ind Farmaceuti Derivati glicosamminoglicani parzialmente desolfatati nonanticoagulanti ad attivita' antiangiogenica.
AU2008202261B2 (en) * 2001-09-12 2011-07-28 Leadiant Biosciences S.A. Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect
SK288335B6 (sk) * 2001-09-12 2016-02-02 Sigma-Tau Research Switzerland S.A. Čiastočne alebo úplne N-desulfatovaný, N-reacetylovaný heparín, spôsob jeho prípravy, jeho použitie na prípravu liečiva s inhibičným účinkom na heparanázu, s antiangiogénnym a protizápalovým účinkom a farmaceutický prostriedok s jeho obsahom
EP2926818A1 (en) 2004-03-26 2015-10-07 La Jolla Pharmaceutical Company Modified pectins, compositions and methods related thereto
WO2009007224A1 (en) * 2007-07-10 2009-01-15 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Low molecular weight heparin derivatives having neuroprotective activity
US9351992B2 (en) 2007-11-02 2016-05-31 Momenta Pharmaceuticals, Inc. Non-anticoagulant polysaccharide compositions
US8569262B2 (en) 2007-11-02 2013-10-29 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
US8592393B2 (en) 2007-11-02 2013-11-26 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
JP5572095B2 (ja) * 2007-11-02 2014-08-13 モメンタ ファーマシューティカルズ インコーポレイテッド 非抗凝固性多糖組成物
US9387256B2 (en) 2010-04-16 2016-07-12 Momenta Pharmaceuticals, Inc. Tissue targeting
US8431826B2 (en) 2010-05-14 2013-04-30 James Robert Howard Capacitive power and ground plane structure utilizing fractal elements for the reduction of radiated emissions
BR112012031906A2 (pt) 2010-06-17 2016-08-23 Momenta Pharmaceuticals Inc métodos e composições para modular o crescimento de cabelo e pelos.
CN104144950B (zh) 2011-12-19 2017-09-05 迪乐方有限责任公司 含有重复的二糖单元的非抗凝的葡糖胺聚糖及其医药用途
WO2013095215A1 (en) 2011-12-19 2013-06-27 Dilaforette Ab Low anticoagulant heparins
ES2699386T3 (es) 2011-12-28 2019-02-11 Galectin Therapeutics Inc Composición de un nuevo fármaco de carbohidratos para el tratamiento de enfermedades humanas
JP6517141B2 (ja) 2012-06-06 2019-05-22 ガレクティン・セラピューティクス・インコーポレイテッドＧａｌｅｃｔｉｎ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． 高誘導型一酸化窒素合成酵素と関連する疾患を処置するためのガラクト−ラムノガラクツロネート組成物
US9507912B2 (en) 2012-08-31 2016-11-29 Nuvectra Corporation Method and system of simulating a pulse generator on a clinician programmer
ES2773921T3 (es) 2012-09-17 2020-07-15 Galectin Therapeutics Inc Método para mejorar las inmunoterapias específicas en el tratamiento del cáncer
BR112015007985A8 (pt) 2012-10-10 2019-08-27 Galectin Therapeutics Inc uso do carboidrato galactose denteada para preparação de composições para tratamento de nefropatia diabética e de distúrbios associados, e suas composições
WO2014130648A1 (en) 2013-02-20 2014-08-28 Galectin Therapeutics, Inc. Method for treatment of pulmonary fibrosis
JP2016520613A (ja) 2013-05-28 2016-07-14 モメンタ ファーマシューティカルズ インコーポレイテッド 薬学的組成物
JP6132302B2 (ja) * 2013-05-28 2017-05-24 リーディアント・バイオサイエンシーズ・ソシエタ・アノニマＬｅａｄｉａｎｔ Ｂｉｏｓｃｉｅｎｃｅｓ Ｓ．Ａ． 抗血管新生活性を有し、抗凝血効果を有さない、ヘパラナーゼ阻害剤としての部分的に脱硫酸化されたグリコサミノグリカンの誘導体
ITLO20130005A1 (it) 2013-10-31 2015-05-01 He E Biochimiche G Ronzonr S R Derivati di glucosamminoglicani n-desolfatati e loro uso come farmaci
ITLO20130006A1 (it) 2013-11-06 2015-05-07 He E Biochimiche G Ronzoni S R Derivati carbossilati di glucosamminoglicani e loro uso come farmaci
CN103724458B (zh) * 2014-01-17 2016-03-30 福州大学 含n-非取代葡萄糖胺肝素六糖的制备及其纯化
WO2016142814A1 (en) 2015-03-06 2016-09-15 Sigma-Tau Research Switzerland S.A. Roneparstat combined therapy of multiple myeloma
JP2016014148A (ja) * 2015-09-10 2016-01-28 シグマ−タウ・リサーチ・スウィッツァーランド・ソシエテ・アノニム 抗血管新生活性を有し、抗凝血効果を有さない、ヘパラナーゼ阻害剤としての部分的に脱硫酸化されたグリコサミノグリカンの誘導体
CN107177015A (zh) * 2016-03-11 2017-09-19 梁颖 一种重乙酰化肝素修饰物及其制备方法和应用
RU2019121873A (ru) 2016-12-13 2021-01-15 БЕТА ТЕРАПЬЮТИКС ПиТиУай ЛТД Ингибиторы гепараназы и их применение
US11787783B2 (en) 2016-12-13 2023-10-17 Beta Therapeutics Pty Ltd Heparanase inhibitors and use thereof
CN108424474B (zh) * 2017-02-15 2023-07-25 清华大学 去抗凝肝素衍生物及其用于炎症性肠病的治疗
WO2019149179A1 (zh) * 2018-02-02 2019-08-08 深圳市海普瑞药业集团股份有限公司 糖胺聚糖衍生物及其制备方法和用途
EP3705126A1 (en) 2019-03-05 2020-09-09 Leadiant Biosciences S.p.A. Roneparstat for the treatment of amyloidosis
WO2021128253A1 (zh) * 2019-12-27 2021-07-01 深圳市海普瑞药业集团股份有限公司 一种糖胺聚糖衍生物及其应用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4500519A (en) * 1978-11-06 1985-02-19 Choay S.A. Mucopolysaccharides having biological properties, preparation and method of use
US5262403A (en) 1986-03-10 1993-11-16 Board Of Regents, The University Of Texas System Glycosaminoglycan derivatives and their use as inhibitors of tumor invasiveness of metastatic profusion-II
IL79255A0 (en) 1986-06-26 1986-09-30 Hadassah Med Org Composition for metastasis prevention
AU7852687A (en) * 1986-08-21 1988-03-08 University Of Texas System, The Glycosaminoglycan derivatives and their use as inhibitors of tumor invasiveness or metastatic profusion
FR2614026B1 (fr) * 1987-04-16 1992-04-17 Sanofi Sa Heparines de bas poids moleculaire, a structure reguliere, leur preparation et leurs applications biologiques
US5280016A (en) * 1991-03-29 1994-01-18 Glycomed Incorporated Non-anticoagulant heparin derivatives
JPH05157344A (ja) * 1991-12-09 1993-06-22 Mitsubishi Heavy Ind Ltd 空気調和機の吹出口
JPH0512822A (ja) 1991-12-16 1993-01-22 Seiko Epson Corp カートリツジ
JPH06157344A (ja) * 1992-02-07 1994-06-03 Childrens Medical Center Corp:The 血管新生阻害のための医薬製剤及び血管新生阻害方法
US5668118A (en) * 1992-07-24 1997-09-16 Cavalier Pharmaceuticals Method of synthesis of 2-O-desulfated Heparin and use thereof for inhibition of elastase and Cathepspin G
US5696100A (en) * 1992-12-22 1997-12-09 Glycomed Incorporated Method for controlling O-desulfation of heparin and compositions produced thereby
US5296471A (en) 1992-12-22 1994-03-22 Glycomed Incorporated Method for controlling o-desulfation of heparin and compositions produced thereby
IT1264709B1 (it) 1993-07-12 1996-10-04 Italfarmaco Spa Derivati eparinici ad attivita' antimetastatica
US5583121A (en) * 1994-01-12 1996-12-10 Michigan State University Non-anticoagulant chemically modified heparinoids for treating hypovolemic shock and related shock syndromes
EP0758247A4 (en) * 1994-05-06 1997-08-20 Glycomed Inc O-DESULFATED HEPARIN DERIVATIVES, METHOD FOR THE PRODUCTION AND USE THEREOF
IL114951A (en) * 1995-08-15 1999-08-17 Hadasit Med Res Service Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization
US5854221A (en) * 1996-12-12 1998-12-29 The Children's Medical Center Corporation Endothelial cell proliferation inhibitor and method of use
CA2237273C (en) * 1996-01-15 2009-01-13 Janssen Pharmaceutica N.V. Angiogenesis inhibiting pyridazinamines
JP4051099B2 (ja) * 1997-01-31 2008-02-20 生化学工業株式会社 低分子化ヘパリン、その製造法及び医薬組成物
IT1296581B1 (it) * 1997-11-28 1999-07-14 Istituto Scient Di Chimica E B Materiali polimerici non trombogenici e ad esaltata compatibilita' con fluidi e tessuti organici
IT1296998B1 (it) * 1997-12-19 1999-08-03 Derivati Organici Lab Composizione costituita da frazioni di eparina avente caratteristiche riproducibili con peso molecolare medio di 5200 d
IT1316986B1 (it) * 2000-01-25 2003-05-26 Sigma Tau Ind Farmaceuti Derivati glicosamminoglicani parzialmente desolfatati nonanticoagulanti ad attivita' antiangiogenica.
US7781416B2 (en) * 2000-01-25 2010-08-24 Sigma-Tau Research Switzerland S.A. Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect

Also Published As

Publication number Publication date
US20030013682A1 (en) 2003-01-16
ITRM20000041A1 (it) 2001-07-25
ES2277911T3 (es) 2007-08-01
US7790700B2 (en) 2010-09-07
CA2397964C (en) 2010-10-12
DE60125154D1 (de) 2007-01-25
CY1108001T1 (el) 2013-09-04
MXPA02007195A (es) 2003-01-28
AU3406401A (en) 2001-08-07
CN1396930A (zh) 2003-02-12
BR0107696A (pt) 2002-10-15
CZ303030B6 (cs) 2012-03-07
KR100812406B1 (ko) 2008-03-11
CZ20022308A3 (cs) 2003-01-15
HU229509B1 (en) 2014-01-28
SK287566B6 (sk) 2011-02-04
HUP0204196A2 (hu) 2003-03-28
US20050222084A1 (en) 2005-10-06
PL357209A1 (en) 2004-07-26
US20100298263A1 (en) 2010-11-25
JP5371167B2 (ja) 2013-12-18
EP1268558B1 (en) 2006-12-13
CA2397964A1 (en) 2001-08-02
DK1268558T3 (da) 2007-04-10
EP1268558A1 (en) 2003-01-02
JP2003523460A (ja) 2003-08-05
IT1316986B1 (it) 2003-05-26
PL209479B1 (pl) 2011-09-30
SK10672002A3 (sk) 2002-12-03
AU782632B2 (en) 2005-08-18
WO2001055221A1 (en) 2001-08-02
US20050107331A1 (en) 2005-05-19
HUP0204196A3 (en) 2003-05-28
KR20020080381A (ko) 2002-10-23
HK1051867A1 (zh) 2003-08-22
US8222231B2 (en) 2012-07-17
CN100540570C (zh) 2009-09-16
PT1268558E (pt) 2007-02-28
DE60125154T2 (de) 2007-10-25
ATE348115T1 (de) 2007-01-15

Similar Documents

Publication Publication Date Title
ITRM20000041A0 (it) Derivati glicosamminoglicani parzialmente desolfatati non anticoagulanti ad attivita' antiangiogenica.
DE60009886D1 (de) Polysaccharidfasern
DE60014371D1 (de) Polysaccharidderivat
TR200000520A3 (tr) 4-Fenil-piridin türevleri.
DE60030303D1 (de) Cannabimimetische indolderivate
NO20014894L (no) Adamantanderivater
NL1016815A1 (nl) Oximester-fotoinitiatoren.
ATE348163T1 (de) Thrombopoietin substitute
NO20022727D0 (no) Adamantanderivater
DE10083667T1 (de) Polyoxymethylenharzzusammensetzung
DE60037233D1 (de) Hämofiltrationsvorrichtung
ATE219157T1 (de) Gleitlager
DE50006093D1 (de) Gleitlagerung
DE50107988D1 (de) Substituierte 1,2,3,4-tetrahydrochinolin-2-carbonsäurederivate
NO20004568D0 (no) Forbrenningsovn
DE60029393D1 (de) Bolzen
DE60025958D1 (de) 14,15-beta-methylen substituierte androgene
EP1150700A4 (en) ANTI-ANGIOGENIC ACTIVE SUBSTANCES
TR200002831A3 (tr) Kinolin-4-Il türevleri I
IT1320849B1 (it) Composizione resist positiva amplificata chimicamente.
ATA12382000A (de) Gleitlager
NO993137L (no) Underrömmer
DE60011095D1 (de) Bügelanordnung
ATA14072000A (de) Regalanlage
DE60134742D1 (de) Selbstentfaltbare katheteranordung